Novo Nordisk said on Tuesday it was working with telehealth firms Hims & Hers , Ro and LifeMD to sell Wegovy, as it looks to ...

Novo Nordisk launched access to its popular weight loss GLP-1 drug, Wegovy, through multiple telehealth platforms, including ...

Novo Nordisk, the maker of Wegovy, announced exclusively on "Good Morning America" Tuesday that the medication will soon be available for purchase through the telehealth companies Ro, Hims and ...

The pharmaceutical company announced it would be partnering with Hims & Hers., LifeMD and Ro. to provide all five dose strengths of its weight-loss GLP-1 medication Wegovy at a reduced cost of $499.

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

Ro teams up with Eli Lilly to offer single-dose vials of weight loss drug Zepbound Hims & Hers and Novo also said the two companies are collaborating beyond the Wegovy partnership but didn't ...

Novo Nordisk A/S is partnering with telehealth companies including Hims & Hers Health Inc., LifeMD Inc., and Ro to offer weight-loss drug Wegovy at lower price. Novo Nordisk A/S is partnering with ...

As part of its deal with Novo, Hims, along with LifeMD Inc., and Ro will sell a month’s supply of Wegovy starting at $499, a 63 percent discount, before subscription fees. Lilly also announced ...

Through NovoCare, Novo’s new direct-to-consumer pharmacy platform, Hims, LifeMD Inc., and Ro will each sell a month’s supply of Wegovy starting at $499. That’s a 63% discount from the drug ...

Hims & Hers Health, LifeMD, Ro, and other platforms like them will now be able to sell Novo Nordisk's Wegovy, which is used for weight loss. The blockbuster GLP-1 should entice customers.

including Hims & Hers Health, Ro, and LifeMD. This development comes just weeks after we highlighted HIMS as a company poised for a turnaround. See - HIMS Stock: Time For A Turnaround? For those ...